Categories

Author Archives

Ryan Bose-Roy

Raspberry Pi Health Care

By KIM BELLARD

Like many of you, I have been intently following the war in Ukraine, cheering for President Zelensky and the Ukrainian people, while hoping it doesn’t end up in WW3.  I thought about trying to write about it, then I saw that Raspberry Pi just turned ten, and I thought, yeah, that’s more my speed.

And, of course, easier to relate to healthcare.

For most of us, a computer is our smartphone, tablet, or laptop.  We buy them already designed and built, complete with an operating system and other useful software.  There’s an almost unlimited range of other software that can easily be downloaded to run on them.  Ease of use is paramount.  

This was not always so.  If you are of a certain age or have studied the history of computers, you’ll know that in the 1970s and early 1980s, (home) computers came in a kit.  You assembled them and figured out what you might want to use them for.  Then came Apple and the PC revolution. Our expectations about what computers could do grew as our expectations about what we had to do diminished.  Between 2006 and 2011, Eben Upton and his collaborators sought to change this.

Continue reading…

How to Talk to Clinicians: Forget Workflows, Just Tell Us How Things Work

BY HANS DUVEFELT

Workflows are all the rage with EMR people. But doctors, NPs and PAs are smart. Nothing burns us out as fast or as completely as being told how to do things instead of why. We are not circus animals.

Let me explain:

If we had no professional education at all, we would have clinical workflows memorized instead of clinical knowledge. For example, two weeks after starting an ACE inhibitor like lisinopril, order a basic metabolic profile. That sounds pretty straightforward, but if you add up all the possible clinical workflows we would need if we didn’t know medicine at all, that would be a huge burden – a massive amount of seemingly random and senseless rules.

Continue reading…

Pithiatism Redux

BY MARTIN SAMUELS

Those of us in medicine have all seen the famous painting of the Tuesday afternoon lessons at the Salpȇtrière in Paris in the 19th century. In Pierre Aristide André Brouillet’s painting, one can clearly see the great professor, Jean-Martin Charcot, holding forth while the patient, Blanche Whitman, is being supported by a tall young man, Joseph Jules Francois Felix Babinski, the Chef de Clinique (the chief resident) and allegedly the favorite to succeed Charcot. He never did as he was failed repeatedly on the exam necessary to become a faculty member at the university by a jealous, xenophobic, anti-immigrant rival, Charles Bouchard. Babinski was born in France and served in the army twice, but his name was Polish as his parents had emigrated to France to escape bias in Poland (sound familiar?).  Ironically almost no one remembers Bouchard (his only contribution being the Charcot-Bouchard aneurysm which may be the cause of some intracerebral hemorrhages), but there is no doctor on earth who does not know Babinski’s name. This is one of many reasons why Babinski is my neurological hero.  

A Clinical Lesson at the Salpêtrière, Pierre Aristide Andé Brouillet
Continue reading…

Get Ready for (Healthcare) Microgrids

BY KIM BELLARD

We depend on it.  Indeed, our daily lives are unimaginable without it.  The trouble is, it’s become unreliable.  Lives have been lost because it wasn’t performing when it needed to be.  It’s built around large facilities that are often decades old.  Parts of it don’t communicate/coordinate well with others.  Its workforce is aging and burnt out.  There is no person or agency charged with ensuring its resiliency. It badly needs to be rethought for the 21st century. 

Oh, you thought I was talking about our nation’s power grid?  I was talking about our healthcare system.  

The parallels are striking, and concerning.  They’re huge industries, based on early 20th century approaches, and beset by 21st-century challenges to which they may not be easily adaptable.  If we don’t manage their evolution to the 21st century right, we’re dead.  Literally.  

Continue reading…

What Would Newt Do? Making Value-Based Care Victorious

By MICHAEL MILLENSON

Health care’s much-trumpeted transition “from volume to value” care remains more tepid than transformational, according to a new study. Looking at 22 health systems nationwide, RAND researchers found that compensation continues to be “dominated by volume-based incentives designed to maximize health systems revenue.”

Although confusing payment schemes bear part of the blame, there are deeper problems that appeared in sharp relief when I chanced upon a long-ago PowerPoint from a prominent political strategist and early advocate of “data-driven reimbursement.” 

I refer, of course, to Newt Gingrich. His recommendations from 2007 about designing transformational change in health care provide a perspective that remains useful today in addressing what is ultimately a political problem. Frankly, value-based care (VBC) advocates perform dismally.

Going Along the Gingrich Roadmap

Back in 2004, Gingrich and I both served on a commission seeking to improve the quality of long-term care. This was during a period when a neutered Newt, out of power, was undergoing a political makeover by championing bipartisan health reform ideas such as electronic health records (EHRs) and evidence-based care. He even shared an award from NCQA with then-New York Sen. Hillary Clinton. 

What Gingrich also shared, often, were his thoughts about what was necessary to drive the kind of sweeping alteration of the status quo represented by his leading Republicans to their first House majority in decades. Reviewing that roadmap, it’s not surprising that VBC advocates remain far from their destination.

The journey starts off in the right direction, with VBC advocates following Gingrich’s advice to “focus on large changes.” Trying to upend the way physicians have been paid since Hippocrates made his first house call certainly qualifies. But ambition has to be articulated as part of an organizing and attractive vision.

In 1997, in a book called Demanding Medical Excellence, I summarized the urgency of what we now call value-based care this way: 

Tens of thousands of patients have died or been injured years after year because readily available information was not used – and is not being used today – to guide their care….(The health care delivery system) must be restructured according to evidence-based medical practice, regular assessment of the quality of care, and accountability.

In a similar vein, Gingrich in 2007 emphasized “a clear and compelling vision for quality” that would appeal to patients and medical professionals by promising safe care (no preventable deaths or injuries); consistent clinical excellence (appropriate and effective evidence-based care); and clinicians and staff partnering with patients.

Language That’s Bureaucratic, Not Bold

In contrast, the coalition sponsoring last month’s Health Care Value Week positioned transformation as a series of “models” addressing a bureaucratic checklist of health care “challenges.” The same type of language is used by the Centers for Medicare & Medicaid Services.

Continue reading…

#HealthTechDeals Episode 11: MindMaze, Memora Health, Ro, PriorAuthNow, and Equip

On this episode of Health Tech Deals, Ian Morrison is pinch-hitting for Jessica DaMassa! Ian and I worked together 25+ years ago, and he’s been sitting in Silicon Valley looking at the American health care system for a long long time. Some deals – MindMaze raises $105M; Memora Health raises $40M; Ro raises $150M; PriorAuthNow raises $25M; Equip raises $58M. Ian also shares his opinions on the American health system and the digital health space–Matthew Holt

TRANSCRIPT

Ian Morrison:

Hi there, I’m Jess DaMassa. Actually, no, Jess DaMassa. Jess DaMassa is a friend of mine and I am no Jess DaMassa. I am Ian Morrison. I am pinch hitting for Jess DaMassa, how could I possibly pinch hit? Matthew told me I had to go and put my kilt on and spruce myself up a bit. But anyway, it’s an honor, a deep honor to be here for the February 18th episode of Health Teach Deals.

Matthew Holt:

So Ian, it’s a Dan Quayle line. No, it’s not the Dan Quayle, it’s the Lloyd Bentsen line about Dan Quayle.

Ian Morrison:

Exactly.

Continue reading…

#HealthTechDeal Episode 10: ANDHealth, Ada Health, Minded, Expressable, and Curve Health

Valentine’s day…is awful. Check out this episode of HealthTechDeals to get Jessica’s and my more in-depth thoughts on the holiday. But let’s see which companies got some financial love this episode: ANDHealth gets $57 million; Ada Health gets another $30m; Minded gets $25 million; Expressable gets $15 million; Curve Health gets $12 million.

-By Matthew Holt

TRANSCRIPT

Jessica DaMassa:

Matthew Holt, was your Valentine’s Day filled with love and kisses and candies and flowers. Uh oh, I take it by the look on your face that’s a big fat no. It’s the February 15th episode of Health Tech Deals. So maybe these startups will feel a little bit more love than you feel right now. What happened?

Matthew Holt:

It’s just that Valentine’s Day in America is stupid, because your kids, I don’t remember this when you were young, because it was a long time ago, but your kids have to take Valentines to everyone in their class. It’s stupid.

Continue reading…

Imaging a Different Future

By KIM BELLARD

Two articles have me thinking this week.  One sets up the problem healthcare has (although healthcare is not explicitly mentioned), while the other illustrates it.  They share being about how we view the future.  

The two articles are Ezra Klein’s Can Democrats See What’s Coming? in The New York Times Opinion pages and Derek Thompson’s Why Does America Make It So Hard to Be a Doctor? in The Atlantic. Both are well worth a read.  

Mr. Klein struck a nerve for me by asking why, when it comes to social insurance programs, Democrats seem so insistent on replicating what has been done before, especially in Western Europe.  He asks: “But what about building here that which does not already exist there?”  He worries “that the Biden administration’s supply-side agenda is stuck in the past and not yet imagining the future.”

Those are exactly the right questions we should be asking about healthcare.

Continue reading…

Will Microbes Finally Force Modernization of the American Health Care System?

BY MIKE MAGEE

Science has a way of punishing humans for their arrogance.

In 1996, Dr. Michael Osterholm found himself rather lonely and isolated in medical research circles. This was the adrenaline-infused decade of blockbuster pharmaceuticals focused squarely on chronic debilitating diseases of aging.

And yet, there was Osterholm, in Congressional testimony delivering this message: “I am here to bring you the sobering and unfortunate news that our ability to detect and monitor infectious disease threats to health in this country is in serious jeopardy…For 12 of the States or territories, there is no one who is responsible for food or water-borne surveillance. You could sink the Titanic in their back yard and they would not know they had water.”

Osterholm’s choice of metaphor perhaps reflected his own frustration and inability to alter the course of the medical-industrial complex despite microbial icebergs directly ahead.

Continue reading…

INSIDE THE ACQUISITION: Signify Health Adds Caravan Health’s ACO-building Expertise for $220M

By JESSICA DaMASSA, WTF HEALTH

Get the details behind the deal! Signify Health (NYSE: SGFY) is acquiring Caravan Health for $220 million in cash and common stock in effort to create one of the largest networks of at-risk healthcare providers in the country. For all those who love healthcare payment model innovation, this is a story about scaling both value-based care and accountable care organizations (ACOs), and we have Signify Health’s CEO Kyle Armbrester and Caravan Health’s founder and Chairwoman Lynn Barr here to explain the model and market potential this creates for Signify Health.

Signify Health is best known for its value-based, care-at-home focused approach in the Medicare Advantage space, and Caravan Health brings both tech and expertise to support the creation of accountable care organizations (ACOs) and the ongoing smart management of their patient populations. Caravan got its start with “safety net providers” in rural areas and pioneered what’s known as the “Collaborative ACO” approach that pools smaller health systems together based on practice similarities (instead of geography) to achieve the right kind of patient scale needed to mitigate risk. This is really important to scaling ACOs nationally, as you’ll hear both Lynn and Kyle explain, and, of course, we ask Kyle to zero-in on how this will extend Signify Health’s reach into new markets as well.

Beyond the acquisition, we also celebrate Signify Health’s one-year IPO-iversary. The company rang the bell on the New York Stock Exchange (then stopped by WTF Health to talk about it!) on Feb 11, 2021. Looking past the Caravan Health acquisition and to what it will lead to next, Kyle and Lynn (who will now be activating even more payment model innovation as Signify Health’s VP of Innovation) get fired up about what’s ahead.

assetto corsa mods